Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 1 group H member 5, pseudogene (NR1H5P), is annotated as a pseudogene and does not encode a functional nuclear receptor protein[4][5]. The broader nuclear receptor family includes important transcription factors involved in hormone sensing, metabolism, and disease[1][3][7], but NR1H5P itself is a non-functional copy and is not considered a therapeutic target. Like other pseudogenes, NR1H5P may theoretically participate in regulatory functions at the RNA level, such as acting as a competitive endogenous RNA, generating regulatory noncoding RNAs, or influencing parental gene expression, although such roles for NR1H5P have not been experimentally validated[2][6]. There is no current evidence that NR1H5P is implicated in disease, interacts with drugs, or serves as a biomarker. Classification as a pseudogene means it is not a receptor, enzyme, transporter, or canonical target, and should not be selected for therapeutic drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 1 group H member 5, pseudogene (NR1H5P).